Should You Buy Canopy Growth (TSX:WEED) Ahead of Earnings?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) releases its Q4 earnings later this month and investors are hoping a good result can help generate some excitement around the stock.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is going to be releasing its quarterly earnings later this month. And with its share price struggling since May, investors might be tempted to buy the stock before it announces its year-end results. Let’s take a closer look at the company to see whether it’s a good idea to buy now.

In its last earnings release back in February, Canopy Growth recorded significant sales growth numbers yet again. However, with a lot of cash burn and soaring expenses, there were plenty of red flags that kept the stock from gaining any momentum. The danger is that in Q4 it could be much of the same, as Canopy Growth has been very busy wheeling and dealing, which is sure to add some significant costs along the way, potentially sending the company  even deeper into the red.

While Canopy Growth is playing the long game and looking to strengthen its position over the years, in the short term, it’s going to lead to a lot of pain. However, investors are aware of these challenges and likely aren’t expecting the company to produce an (operating) profit anytime soon. Otherwise, Canopy Growth wouldn’t be at a market cap of around $20 billion today.

Is excitement surrounding Canadian pot stocks fading?

The big risk for Canopy Growth isn’t related to its financials or whether it will meet expectations; rather, it’s that investors have so many more options to choose from, as the U.S. cannabis industry has been growing and capturing a lot of attention lately. There’s no denying that the opportunity south of the border is a lot more lucrative given how strong sales have been in California and in other states.

While Canopy Growth certainly looks to capitalize that through its plans for hemp and the acquisition of Acreage Holdings, it’s still a long-term play that could take years to be realized. Meanwhile, companies in the U.S. are already expanding their reach throughout the country.

In order for investors to get excited about Canopy Growth, the company will have to announce some progress or expectations for its plans for the U.S. because strong results in Canada may not be enough to lift the stock from where it is today. Industry developments or company announcements have typically given Canopy Growth a big boost in the past. Investors have looked for signs of the growth that might be coming down the pipe rather than what has already been achieved thus far.

Bottom line

Barring a significant announcement made at the Q4 release, I would be surprised if the company sees a big boost in its share price even after a strong earnings result. However, given we’ve seen many misses in the industry since legalization, I wouldn’t hold out hope that Canopy Growth will produce a positive surprise this time around.

It may not be until edibles are legalized until we see some excitement returning to Canadian pot stocks. For now, however, the focus appears to have shifted away, and while that might make Canopy Growth an appealing buy today given its softer price, I wouldn’t expect the stock to get a big boost after the company releases its earnings this month.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »